Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA) (PROSTIRNA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02866916
Recruitment Status : Withdrawn (Study cancelled)
First Posted : August 15, 2016
Last Update Posted : January 20, 2021
Information provided by (Responsible Party):
Institut Claudius Regaud

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : June 2020